GBT Announces New Phase 2a Data at ASH for Voxelotor in Adolescents with Sickle Cell Disease (SCD)
Dec 09, 2017 15:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 09, 2017 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced new results from its ongoing Phase 2a HOPE-KIDS 1 Study of once-daily oral therapy, voxelotor...
Dec 09, 2017 14:30 pm UTC| Business
Subcutaneous (SQ) delivery significantly increases half-life of CB 2679d to 98.7 hours Data supports potential normalization of FIX activity with daily or less-frequent SQ dosing SOUTH SAN FRANCISCO, Calif., Dec. 09,...
Dec 09, 2017 14:00 pm UTC| Business
Non-human primate study of AMT-061 utilizing FIX-Padua shows 6.5-fold increase in FIX clotting activitycompared to AMT-060 Data supports nonclinical comparability plan agreed upon with FDA LEXINGTON, Mass. and...
Dec 09, 2017 14:00 pm UTC| Business
CAMBRIDGE, Mass. and BEIJING, China, Dec. 09, 2017 -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and...
Dec 09, 2017 13:30 pm UTC| Business
NEW YORK, Dec. 09, 2017 -- Pomerantz LLP announces that a class action lawsuit has been filed against Alkermes plc (“Alkermes” or the “Company”) (NASDAQ:ALKS) and certain of its officers. The class action, filed in...
Dec 09, 2017 13:15 pm UTC| Business
NEW YORK, Dec. 09, 2017 -- Pomerantz LLP announces that a class action lawsuit has been filed against Omega Healthcare Investors, Inc. (“Omega” or the “Company”) (NYSE:OHI) and certain of its officers. The class...
Dec 09, 2017 13:00 pm UTC| Business
La Chaux-de-Fonds, Switzerland, Dec. 09, 2017 -- Rhizen Pharmaceuticals S.A., today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for RP6530 (tenalisib), the Company’s...
FxWirePro- Major Economic Events for teh day
Shiba Inu’s Shytoshi Kusama Drops Bold Crypto Data from Gemini—Youth Surge Fuels SHIB’s Next Move